Teva Pharmaceutical Industries net profit according to GAAP for 6 months of 2021 amounted to $306 million, increasing 3.9 times compared to $78 million in the previous year. Revenues decreased 4.1% to $7.892 billion from $8.227 billion a year earlier.
Teva Pharmaceutical Industries net profit according to GAAP for 6 months of 2021 amounted to $306 million, increasing 3.9 times compared to $78 million in the previous year. Revenues decreased 4.1% to $7.892 billion from $8.227 billion a year earlier. 
ir.tevapharm.com
English (US) 